[1] Wang Z, Xu M, Peng J, et al. Prevalence and associated metabolic factors of fatty liver disease in the elderly. Exp Gerontol, 2013, 48:705-709. [2] 中华医学会糖尿病学分会.中国2型糖尿病防治指南.中华糖尿病杂志,2014,6:447-498. [3] 中国成人血脂异常防治指南制定联合委员会.中国成人血脂异常防治指南.中华心血管病杂志,2007,35:390-419. [4] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南. 中华肝脏病杂志,2010,18:167-170. [5] Reddy JK, Rao MS. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol, 2006, 290:G852-858. [6] Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol,2009, 50:204-210. [7] Huang Y, Bi Y, Xu M, et al. Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese .Arterioscler Thromb Vasc Biol,2012, 32:2321-2326. [8] Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology, 2009, 49:1017-1044. [9] Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis, 2007, 191:235-240. [10] 李秀萍,丁丹,王龙.1843例45岁以上公务员健康体检结果分析.宁夏医学杂志,2015,37:1221-1222. [11] 张春娇,孙昕霙.吉林地区304名公务员健康状况与生活方式调查.中国健康教育,2013,29:654-656. [12] 赵红玲,宁加玲.南宁市3956例公务员体检中脂肪肝患病情况调查.内科,2007,2:42-43. [13] 陈贻平,刘建兵,张秋元,等.海南省管理人员体检脂肪肝的患病率调查.中国热带医学,2008,8:501-503. [14] Liao XH, Cao X, Liu J, et al. Prevalence and features of fatty liver detected by physical examination in Guangzhou. World J Gastroenterol, 2013, 19: 5334-5339. [15] Guarner-Lans V, Rubio-Ruiz ME, Perez-Torres I, et al. Relation of aging and sex hormones to metabolic syndrome and cardiovascular disease. Exp Gerontol, 2011, 46:517-523. [16] Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J Gastroenterol Hepatol,2013,28(Suppl):11-17. [17] 魏国华,刘兰,蔡晓波,等.高脂饮食所致动脉粥样硬化家兔肝组织学损伤评估. 中国动脉硬化杂志, 2008, 16:373-375. [18] Yki-Jarvinen H. Fat in the liver and insulin resistance. Ann Med, 2005, 37:347-356. [19] Xu J, Qiu J, Chen J, et al. Lifestyle and health-related quality of life: a cross-sectional study among civil servants in China. BMC Public Health, 2012, 12:330. [20] Nobili V, Alkhouri N, Alisi A, et al. Retionl binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol, 2009, 7:575-579. |